BackIdeaya Biosciences Overview
Ideaya Biosciences Inc

Ideaya Biosciences Target Price

Where could IDYA trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$36.68

Average Target Price

$57.0055.4% upside

3 analysts in the last 4 months

High: $63 | Low: $48

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05Wedbush$6063.6% upsideOpen
2026-07-07Truist FinancialGregory Renza$6371.8% upsideOpen
2026-07-07RBC Capital$4830.9% upsideOpen
2026-04-14Wedbush$5858.1% upsideOpen
2026-04-14RBC Capital$5344.5% upsideOpen
2026-04-13Truist Financial$6577.2% upsideOpen
2026-02-18Wedbush$5241.8% upsideOpen
2026-01-21RBC Capital$4522.7% upsideOpen
2026-01-06Truist FinancialGregory Renza$6063.6% upsideOpen
2025-11-24Truist Financial$5960.9% upsideOpen
2025-10-21New Street$3018.2% downsideOpen
2025-10-21RBC Capital$4111.8% upsideOpen
2025-09-17Guggenheim$5036.3% upsideOpen
2025-09-09RBC CapitalGregory Renza$383.6% upsideOpen
2025-09-08OppenheimerMatthew Biegler$361.9% downsideOpen
2025-09-04JMP Securitieslvan Tuerkcan$4111.8% upsideOpen
2025-09-04Barclays$409.1% upsideOpen
2024-11-05Leerink PartnersAndrew Berens$2726.4% downsideOpen
2024-10-24UBSDavid Dai$5036.3% upsideOpen
2024-09-25Mizuho SecuritiesGraig Suvannavejh$5549.9% upsideOpen
2024-09-23Goldman SachsCorinne Jenkins$4830.9% upsideOpen
2024-09-23Stifel NicolausBen Burnett$6679.9% upsideOpen
2024-09-23BTIGJustin Zelin$6269% upsideOpen
2024-09-10Stifel NicolausBen Burnett$6885.4% upsideOpen
2024-08-27CitigroupYigal Nochomovitz$5858.1% upsideOpen
2024-08-07OppenheimerMatthew Biegler$5344.5% upsideOpen
2024-07-10RBC CapitalGregory Renza$6166.3% upsideOpen
2024-07-08Mizuho SecuritiesGraig Suvannavejh$5036.3% upsideOpen
2024-06-03Stifel NicolausBen Burnett$6371.8% upsideOpen
2022-12-28Capital One Financial$2920.9% downsideOpen
2022-09-13Guggenheim$3212.8% downsideOpen
2022-08-18Oppenheimer$2045.5% downsideOpen
2022-08-16Robert W. Baird$1850.9% downsideOpen

Ideaya Biosciences (IDYA) FAQ

Ideaya Biosciences (IDYA) currently reports a target price of $57. Use the charts on this page to explore Ideaya Biosciences's target price history and peer comparisons.

Analysts' average 12-month price target for Ideaya Biosciences is $57, about 55.4% upside from the current share price of $36.68. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $57, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ideaya Biosciences, and consider following IDYA for alerts when major investors trade the stock.

Ideaya Biosciences is classified in the Healthcare sector. On target price, it currently shows $57. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDYA with unrelated industries.